ANIP - ANI Pharma wins FDA nod for generic Indocin
2024-01-16 07:10:45 ET
More on ANI Pharmaceuticals
- ANI Pharmaceuticals: A New Assessment
- ANI Pharmaceuticals, Inc. (ANIP) Q3 2023 Earnings Call Transcript
- 3 Catalysts Could Drive ANI Pharmaceuticals' PPS Growth Through November 2023
- ANI Pharmaceuticals Non-GAAP EPS of $1.27 beats by $0.43, revenue of $131.83M beats by $19.91M
- ANI Pharmaceuticals Q3 2023 Earnings Preview
For further details see:
ANI Pharma wins FDA nod for generic Indocin